CareLit Fachartikel

Outlook on improving pharmacotherapy in schizophrenia

F.M Werner, R Covenas · Aktuelle Neurologie · 2008 · Heft 09

Dokument
1133824
CareLit-ID
Jahr
2008
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
F.M Werner, R Covenas
Ausgabe
Heft 09 / 2008
Seiten
–
Erschienen: 2008-09-02 00:00:00
ISSN
0302-4350

Zusammenfassung

Schizophrenia is undoubtedly an inheritable disorder. Hypoactivity of gamma-aminobutyric acid (GABA) is encoded in the GAD 67 gene and of glutamate in the neuregulin-1 and dysbindin-1 genes. The COMT gene, which catalyzes deactivation of dopamine, is associated with dopamine hyperactivity. In the pathophysiology of schizophrenia, hyperactivity of dopamine and serotonin and hypoactivity of glutamate and GABA have been described in the mesolimbic system, but in addition, alterations in the level of neuropeptides in schizophrenic patients have been reported. In the mesolimbic system of schizophrenic patients, the f…

Schlagworte

5-HT2A-Antagonist Aktuelle Neurologie